Senna Liquid Syrup
NDC Package 84447-120-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Senna Liquid syrups is sennosides are used to treat constipation. This formulation utilizes a syrup delivery system. Marketed by Belleview Biosciences, this product is identified by NDC 84447-120 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
84447-120-01
Package Description
200000 mL in 1 DRUM
Product Code
84447-120
11-Digit Billing Format
84447012001
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Senna Liquid
Non-Proprietary Name
Senna Liquid
Substance Name
Sennosides
Dosage Form
Syrup - An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
SENNOSIDES 8.8 mg/5mL
Usage Information
Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.

Regulatory & Marketing

Labeler Name
Belleview Biosciences
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-01-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84447-120-01 identifies a specific commercial package of 200000 ml in 1 drum of Senna Liquid, a human over the counter drug labeled by Belleview Biosciences. This syrup is formulated for oral use and contains sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Belleview Biosciences on May 01, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.

How is this Belleview Biosciences product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84447012001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84447-120-01
11-Digit CMS (5-4-2)
84447-0120-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.